These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10687857)

  • 1. Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor.
    Yoh SM; Privalsky ML
    Mol Cell Endocrinol; 2000 Jan; 159(1-2):109-24. PubMed ID: 10687857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors.
    Yoh SM; Chatterjee VK; Privalsky ML
    Mol Endocrinol; 1997 Apr; 11(4):470-80. PubMed ID: 9092799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor.
    Yoh SM; Privalsky ML
    J Biol Chem; 2001 May; 276(20):16857-67. PubMed ID: 11278601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
    Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
    J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
    Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
    Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel TR beta mutation (R383H) in resistance to thyroid hormone syndrome predominantly impairs corepressor release and negative transcriptional regulation.
    Clifton-Bligh RJ; de Zegher F; Wagner RL; Collingwood TN; Francois I; Van Helvoirt M; Fletterick RJ; Chatterjee VK
    Mol Endocrinol; 1998 May; 12(5):609-21. PubMed ID: 9605924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.
    Safer JD; Cohen RN; Hollenberg AN; Wondisford FE
    J Biol Chem; 1998 Nov; 273(46):30175-82. PubMed ID: 9804773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear corepressors recognize distinct nuclear receptor complexes.
    Cohen RN; Putney A; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone.
    Collingwood TN; Wagner R; Matthews CH; Clifton-Bligh RJ; Gurnell M; Rajanayagam O; Agostini M; Fletterick RJ; Beck-Peccoz P; Reinhardt W; Binder G; Ranke MB; Hermus A; Hesch RD; Lazarus J; Newrick P; Parfitt V; Raggatt P; de Zegher F; Chatterjee VK
    EMBO J; 1998 Aug; 17(16):4760-70. PubMed ID: 9707435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate.
    Furlanetto TW; Kopp P; Peccin S; Gu WX; Jameson JL
    Mol Genet Metab; 2000 Nov; 71(3):520-6. PubMed ID: 11073720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain.
    Huber BR; Desclozeaux M; West BL; Cunha-Lima ST; Nguyen HT; Baxter JD; Ingraham HA; Fletterick RJ
    Mol Endocrinol; 2003 Jan; 17(1):107-16. PubMed ID: 12511610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
    Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
    J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
    Tagami T; Jameson JL
    Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndromes of thyroid hormone resistance.
    Beck-Peccoz P; Mannavola D; Persani L
    Ann Endocrinol (Paris); 2005 Jun; 66(3):264-9. PubMed ID: 15988389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms by which thyroid hormone receptor mutations cause clinical syndromes of resistance to thyroid hormone.
    Jameson JL
    Thyroid; 1994; 4(4):485-92. PubMed ID: 7711514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary resistance to thyroid hormone syndrome is associated with T3 receptor mutants that selectively impair beta2 isoform function.
    Wan W; Farboud B; Privalsky ML
    Mol Endocrinol; 2005 Jun; 19(6):1529-42. PubMed ID: 15802373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
    J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
    Hong SH; Wong CW; Privalsky ML
    Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.